Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+3.27%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$140M
Cap. Flow
% of AUM
1.93%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| 1 |
Biogen
BIIB
|
+$41.1M |
| 2 |
Intuit
INTU
|
+$38.1M |
| 3 |
Ecolab
ECL
|
+$37.8M |
| 4 |
Autodesk
ADSK
|
+$37.6M |
| 5 |
Coca-Cola
KO
|
+$36.5M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$40.4M |
| 3 |
EOG Resources
EOG
|
+$33.8M |
| 4 |
Microsoft
MSFT
|
+$31.4M |
| 5 |
Ford
F
|
+$30.2M |
Sector Composition
| 1 | Technology | 18.64% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.44% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
MEI Pharma
MEIP
$91.3M
| $339K | ﹤0.01% |
6,776
+5,919
| +691% | +$296K |
|
802
Accenture
ACN
$159B
| $335K | ﹤0.01% |
1,813
-590
| -25% | -$109K |
|
|
CNST
803
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $329K | ﹤0.01% |
+26,801
| New | +$329K |
|
804
Spyre Therapeutics
SYRE
$1B
| $328K | ﹤0.01% |
+1,914
| New | +$328K |
|
|
ISEE
805
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $323K | ﹤0.01% |
248,261
-69,686
| -22% | -$90.7K |
|
806
NextEra Energy, Inc.
NEE
$144B
| $315K | ﹤0.01% |
+6,160
| New | +$315K |
|
807
Home Bancorp
HBCP
$442M
| $312K | ﹤0.01% |
8,116
+1,860
| +30% | +$71.5K |
|
|
AGTC
808
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $309K | ﹤0.01% |
81,624
+18,265
| +29% | +$69.1K |
|
809
US Bancorp
USB
$75.7B
| $308K | ﹤0.01% |
5,870
+280
| +5% | +$14.7K |
|
|
SRC
810
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $307K | ﹤0.01% |
+7,190
| New | +$307K |
|
|
AAT
811
American Assets Trust
AAT
$1.27B
| $306K | ﹤0.01% |
+6,500
| New | +$306K |
|
|
JNCE
812
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $306K | ﹤0.01% |
61,766
+46,266
| +298% | +$229K |
|
|
NSTG
813
DELISTED
NanoString Technologies, Inc.
NSTG
| $304K | ﹤0.01% |
10,000
| – | – |
|
|
BHR
814
Braemar Hotels & Resorts
BHR
$203M
| $298K | ﹤0.01% |
30,399
+4,767
| +19% | +$46.7K |
|
815
Syndax Pharmaceuticals
SNDX
$1.41B
| $298K | ﹤0.01% |
32,032
+15,832
| +98% | +$147K |
|
816
H.B. Fuller
FUL
$3.39B
| $297K | ﹤0.01% |
6,410
+1,520
| +31% | +$70.4K |
|
817
Myers Industries
MYE
$600M
| $297K | ﹤0.01% |
+15,400
| New | +$297K |
|
818
Gulf Island Fabrication
GIFI
$120M
| $296K | ﹤0.01% |
41,713
+5,500
| +15% | +$39K |
|
819
Enpro
NPO
$4.62B
| $292K | ﹤0.01% |
4,572
| – | – |
|
820
Zebra Technologies
ZBRA
$16B
| $289K | ﹤0.01% |
1,380
| – | – |
|
821
Astec Industries
ASTE
$1.08B
| $285K | ﹤0.01% |
8,749
-3,000
| -26% | -$97.7K |
|
822
Scholar Rock
SRRK
$3.04B
| $282K | ﹤0.01% |
+17,770
| New | +$282K |
|
823
Freshpet
FRPT
$2.72B
| $281K | ﹤0.01% |
+6,170
| New | +$281K |
|
824
Qualys
QLYS
$4.88B
| $281K | ﹤0.01% |
+3,230
| New | +$281K |
|
|
FTSV
825
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $279K | ﹤0.01% |
+26,358
| New | +$279K |
|